Influence of Dose and Antiepileptic Comedication on Lacosamide Serum Concentrations in Patients With Epilepsy of Different Ages

被引:19
|
作者
May, Theodor W. [1 ]
Helmer, Renate [1 ]
Bien, Christian G. [2 ]
Brandt, Christian [2 ]
机构
[1] Mara Hosp, Soc Epilepsy Res, Bielefeld, Germany
[2] Mara Hosp, Bethel Epilepsy Ctr, Bielefeld, Germany
关键词
lacosamide; antiepileptic drugs; drug interactions; age; therapeutic drug monitoring; NO PHARMACOKINETIC INTERACTION; TOTAL-BODY WATER; VALPROIC ACID; ADULTS; METHSUXIMIDE; CHILDREN;
D O I
10.1097/FTD.0000000000000538
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Lacosamide (LCM) is a new antiepileptic drug (AED). The purpose of the study was to investigate the effects of LCM dose, body weight, height, sex, age, and concomitant AEDs on LCM trough serum concentrations (at a steady state) in patients with epilepsy. Methods: A total number of 3154 blood samples of 973 consecutive patients of the Mara Hospital (Bethel Epilepsy Centre) were evaluated. Generalized estimating equation (GEE) models were used for statistical analyses. Results: GEE analyses showed that LCM trough serum concentrations were significantly correlated with the body weight-normalized LCM dose (range: 0.44-25.7 mg/kg; 45-1050 mg) and significantly dependent on comedication and age. Compared with adults (18-60 years), the LCM trough serum concentrations of children aged 6-12 years and children younger than 6 years were significantly lower (-21% to -38%, respectively) and those of elderly patients (. 60 years) were significantly higher (+20%). Sex had no significant influence. Carbamazepine, phenytoin, primidone, phenobarbital, and methsuximide decreased LCM trough serum concentrations significantly by 30%, 32%, 34%, 39%, and 41%, respectively, whereas other AEDs (eg, oxcarbazepine, eslicarbazepine acetate, valproate) had no significant or only a minor impact (zonisamide) on LCM trough concentrations. In children, the effect of enzyme-inducing AEDs was more marked. Of note, the number of blood samples (n = 151) of patients younger than 12 (n = 78) was comparatively low. Alternative GEE models confirmed the effect of comedication, whereas the effect of age, especially in children, depended on adjustment of LCM dosage to body weight, body surface area, or approximated volume of distribution. Conclusions: In accordance with previous therapeutic drug monitoring studies, our results confirmed that enzyme inducers reduce the LCM trough serum concentrations by 30%-40%. In children, the effects of comedication are more pronounced but should be confirmed by further studies.
引用
收藏
页码:620 / 627
页数:8
相关论文
共 50 条
  • [21] Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication:: Results of a retrospective study
    May, TW
    Rambeck, B
    Jürgens, U
    THERAPEUTIC DRUG MONITORING, 1999, 21 (02) : 175 - 181
  • [22] Influence of Concomitant Antiepileptic Drugs on Plasma Lamotrigine Concentration in Adult Japanese Epilepsy Patients
    Yamamoto, Yoshiaki
    Inoue, Yushi
    Matsuda, Kazumi
    Takahashi, Yukitoshi
    Kagawa, Yoshiyuki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (04) : 487 - 493
  • [23] Clinical impact of the dose and blood concentration of lacosamide in Japanese pediatric patients with epilepsy: A cohort study
    Ishikawa, Nobutsune
    Eguchi, Yuta
    Izumo, Hiroki
    Tateishi, Yuichi
    Tani, Hiroo
    Kobayashi, Yoshiyuki
    Okada, Satoshi
    EPILEPSY & BEHAVIOR, 2022, 129
  • [24] Influence of age and comedication on steady-state clonazepam serum level-dose ratios in Japanese epileptic patients
    Yukawa, E
    Satou, M
    Nonaka, T
    Yukawa, M
    Ohdo, S
    Higuchi, S
    Kuroda, T
    Goto, Y
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2001, 26 (05) : 375 - 379
  • [25] Influence of CYP2C19 Polymorphism and Concomitant Antiepileptic Drugs on Serum Clobazam and N-Desmethyl Clobazam Concentrations in Patients With Epilepsy
    Yamamoto, Yoshiaki
    Takahashi, Yukitoshi
    Imai, Katsumi
    Miyakawa, Kou
    Nishimura, Shigeko
    Kasai, Risa
    Ikeda, Hiroko
    Takayama, Rumiko
    Mogami, Yukiko
    Yamaguchi, Tokito
    Terada, Kiyohito
    Matsuda, Kazumi
    Inoue, Yushi
    Kagawa, Yoshiyuki
    THERAPEUTIC DRUG MONITORING, 2013, 35 (03) : 305 - 312
  • [26] Saliva and serum levetiracetam concentrations in patients with epilepsy
    Meearelli, Oriano
    Voti, Pietro Li
    Pro, Stefano
    Romolo, Francesco Saverio
    Rotolo, Maria
    Pulitano, Patrizia
    Accornero, Neri
    Vanacore, Nicola
    THERAPEUTIC DRUG MONITORING, 2007, 29 (03) : 313 - 318
  • [27] How to handle a missed or delayed dose of lacosamide in pediatric patients with epilepsy? a mode-informed individual dosing
    Wang, Jun
    Mei, Yan
    Liang, Song
    Li, Si-Chan
    Chen, Chen
    Nie, Gang
    Tuo, Ya-Li
    Sun, Dan
    Wang, Yang
    EPILEPSY & BEHAVIOR, 2024, 151
  • [28] Twelve-Month Efficacy of Lacosamide Monotherapy at Maximal Dose and Tolerability for Epilepsy Treatment in Pediatric Patients: Real-World Clinical Experience
    Zhao, Ting
    Li, Hong-jian
    Zhang, Hui-lan
    Yu, Jing
    Feng, Jie
    Wang, Ting-ting
    Sun, Yan
    Yu, Lu-hai
    PEDIATRIC NEUROLOGY, 2023, 142 : 23 - 30
  • [29] Factors Influencing Serum Topiramate Concentrations in Routine Therapeutic Drug Monitoring in Korean Adult Patients With Epilepsy
    Huh, Hee Jae
    Joo, Eun Yeon
    Hong, Seung Bong
    Ahn, Joong Hyun
    Seo, Dae-Won
    Lee, Soo-Youn
    THERAPEUTIC DRUG MONITORING, 2013, 35 (02) : 177 - 182
  • [30] Influence of enzyme inducing antiepileptic drugs on the pharmacokinetics of levetiracetam in patients with epilepsy
    Freitas-Lima, Priscila
    Alexandre, Veriano, Jr.
    Leira Pereira, Leonardo Regis
    Feletti, Fausto
    Perucca, Emilio
    Sakamoto, Americo Ceiki
    EPILEPSY RESEARCH, 2011, 94 (1-2) : 117 - 120